NYSE: ULUnilever PLC Stock
$64.22-1.21 (-1.85%)
Updated Apr 23, 2025
UL Price
$64.22
Fair Value Price
N/A
Market Cap
$162.16B
52 Week Low
$50.28
52 Week High
$65.87
P/E
25.69x
P/B
7.46x
P/S
2.24x
PEG
1.84x
Dividend Yield
2.92%
Revenue
$66.04B
Earnings
$5.98B
Gross Margin
15.5%
Operating Margin
15.4%
Profit Margin
9.5%
Debt to Equity
2.86
Operating Cash Flow
$13B
Beta
0.36
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
UL Overview
Unilever Public Limited Company is a multinational consumer goods company. Segments include Beauty & Personal Care, Foods & Refreshment, and Home Care. The company offers its products under the Domestos, OMO, Seventh Generation, Ben & Jerry's, Knorr, Magnum, Wall's, Bango, the Vegetarian Butcher, Axe, Cif, Comfort, Dove, Lifebuoy, Lux, Rexona, Sunsilk, Equilibra, OLLY, Liquid I.V., SmartyPants, Onnit, Hellmann's, and Vaseline brands. Unilever was incorporated in 1894 and is headquartered in London, UK.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine UL's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Household & Personal Product
Industry Rating
C
UL
Ranked#2 of 25
Ranked#2 of 25
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $26.71 | B | |
| $4.59 | C | |
| $34.12 | C |
Be the first to know about important UL news, forecast changes, insider trades & much more!
UL News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how UL scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
UL ($64.22) is trading above its intrinsic value of $25.32, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
UL is good value based on its earnings relative to its share price (25.69x), compared to the US market average (26.95x)
P/E vs Market Valuation
UL is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more UL due diligence checks available for Premium users.
Valuation
UL price to earnings (PE)
For valuing profitable companies with steady earnings
Company
25.69x
Industry
25.8x
Market
26.95x
UL is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
UL is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
UL price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
7.46x
Industry
7.46x
UL is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
UL price to earnings growth (PEG)
For valuing profitable companies with growth potential
UL is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
UL's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
UL's Earnings (EBIT) of $10.17B... subscribe to Premium to read more.
Interest Coverage Financials
UL's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$83.1B
Liabilities
$59.6B
Debt to equity
2.86
UL's short-term liabilities ($27.43B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
UL's long-term liabilities ($34.74B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
UL's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
UL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
UL's operating cash flow ($13.20B)... subscribe to Premium to read more.
Debt Coverage Financials
UL vs Household & Personal Product Stocks
Unilever Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.